all report title image
  • Published On : Jun 2022
  • Code : CMI4949
  • Industry : Pharmaceutical
  • Pages : 175
  • Formats :

Injectable pharmaceutical drug delivery system can be used as an alternative to oral drug delivery system. An injection is considered a form of parenteral drug administration, and it allows the medication to be absorbed more rapidly.

Africa injectable drugs market is estimated to be valued at US$ 284.5 Mn in 2022 and expected to exhibit a CAGR of 4.7% during the forecast period (2022-2030).

Figure 1. Africa Injectable Drugs Market Share (%) in Terms of Value, by Molecule Type, 2022

Africa Injectable Drugs  | Coherent Market Insights

The increasing prevalence of chronic diseases such as cardiovascular, diabetes, cancer, etc. is expected to drive the market growth during the forecast period.

Sedentary lifestyle and changes in dietary habits i.e. the consumption of fats and sugar-rich diet lead to an increase in cases of obesity and thereby increase the risk of cardiovascular diseases and diabetes. For instance, according to the International Diabetes Federation, in 2019, an estimated 19.4 million adults aged 20-79 years were living with diabetes in Africa.

CMI table icon

Africa Injectable Drugs Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 284.5 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 4.7% 2030 Value Projection: US$ 410.9 Mn
Geographies covered:
  • Africa: North Africa, Central Africa, and South Africa
Segments covered:
  • By Molecule Type: Large Molecule, Small Molecule
  • By Route of Administration: Intravenous, Intramuscular, Sub-cutaneous, Others
  • By End User: Hospitals, Specialty Clinics, Others
Companies covered:

Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma gmbh,  Merck & Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.

Growth Drivers:
  • Increase in the prevalence of chronic diseases
  • Growing manufacturing facilities for pharmaceutical drugs
Restraints & Challenges:
  • Lack of funding for manufacturing injectable products

Figure 2. Africa Injectable Drugs Market Share (%), by End User, 2022

Africa Injectable Drugs  | Coherent Market Insights

Growing manufacturing facilities for pharmaceutical drugs are expected to drive the market growth during the forecast period.

The ever-growing number of healthcare practitioners leads to a surge in the demand for injectable drugs. For instance, in Africa estimated there were about 266,279 doctors in 2020. Thus, key market players are engaged in enhancing their manufacturing capabilities and strengthening their position in the market, which will drive the market growth. For instance, in sub-Saharan Africa, only Kenya, Nigeria, and South Africa have a relatively considerable industry with a significant number of manufacturing companies. Moreover, initiatives by governments and market players to develop a local drug industry in sub-Saharan Africa is expected to create a significant opportunity for the market players.

Africa Injectable Drugs Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization (WHO) declared it a public health emergency on January 30, 2020.

The COVID-19 can affect the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets.

Africa Injectable Drugs Market: Restraint

The major factors that hinder the growth of Africa injectable drugs market include the lack of funding for manufacturing injectable products. Lack of finances can also be a significant challenge to manufacturing injectable pharmaceuticals.

Key Players

Major players operating in Africa injectable drugs market include Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma gmbh, Merck & Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.

Injectable drugs are injected by various routes of administration, such as intravenous, intramuscular, sub-cutaneous, etc. to treat a number of diseases such as cardiovascular, respiratory, cancer, etc. Healthcare professionals can inject many medications into different parts of the body. They will decide the most appropriate route of access depending on the situation.

Market Dynamics

Rapid therapeutic effect of injectable drugs is leads to increase the demand for the injectable products. Thus, key market players are engaged in enhancing manufacturing facilities of pharmaceutical products and strengthening their market position in Africa. This, in turn, is expected to drive the market growth. For instance, the African Union Commission (AUC) and the United Nations Industrial Development Organization (UNIDO) developed a business plan to accelerate the implementation of the Pharmaceutical Manufacturing Plan for Africa (PMPA), with funding from the German government. Moreover, injectable drugs offer potential benefits to patients with human immunodeficiency virus (HIV) on anti-retroviral therapy (ART) in low-income settings in sub-Saharan Africa. This in turn to increase usage of injectable drugs to treat HIV patients and thereby drive the growth of market in Africa. Furthermore, surge in presence of branded formulations is anticipated to drive the growth of market. For instance, branded formulations for bupivacaine injection such as Macaine HCL, (0.5% for spinal injection), Macaine HCL, (0.5% for injection with Dextrose), and Macaine HCL, (0.5% injection) are available in African countries, majorly in South Africa. Major manufacturers in Africa such as Pharma-Q Holdings (Pty) Ltd. and Adcock Ingram Limited offer bupivacaine injection in South Africa and other countries in Africa. In addition, manufactures operating in the market are appointing a distributors and thus increases the number of suppliers. This in turn to propel the growth of market. For instance, online distributors/pharmacies such as Seif Pharmacy in Egypt offers Isoptin (5 mg / 2ml) in the country. Pharmaceutical suppliers such as Pharmachemie (Pty) Ltd. and Sanofi-Aventis South Africa (Pty) Ltd. supply Fludarabine brands to the Department of Health, South Africa

Key features of the study:

  • This report provides an in-depth analysis of Africa injectable drugs market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in Africa injectable drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma GmBH, Merck & Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Africa injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing Africa injectable drugs market

Detailed Segmentation:

  • Africa Injectable Drugs Market, By Molecule Type:
    • Large Molecule
    • Small Molecule
  • Africa Injectable Drugs Market, By Route of Administration:
    • Intravenous
    • Intramuscular
    • Sub-cutaneous
    • Others
  • Africa Injectable Drugs Market, By End User:
    • Hospitals
    • Specialty Clinics
    • Others
  • Africa Injectable Drugs Market, By Country/Region:
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
    • Fresenius Kabi India Pvt. Ltd.
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Apotex Inc.
    • Hikma Pharmaceuticals PLC
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • Gland Pharma Limited
    • hameln pharma gmbh
    • Merck & Co., Inc.
    • AbbVie Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Aurobindo Pharma
    • PANPHARMA S.A.

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

Africa injectable drugs market is estimated to be valued at US$ 284.5 million in 2022 and expected to exhibit a CAGR of 4.7% between 2022 and 2030.
Factors such as an increase in the prevalence of chronic disease and number of manufacturing facilities are expected to drive the market growth during the forecast period.
Small molecule is the leading molecule type segment and is expected to hold a major market share during the forecast period.
The major factors hampering the growth of the market include the lack of funding for manufacturing injectable products.
Major players operating in the market include Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma gmbh, Merck & Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo